Biofarma Group produces nutraceuticals and food supplements for third parties, capable of preventing chronic diseases and improving health status.
Biofarma Group develops products containing probiotics, capable of protecting the body by strengthening the intestinal ecosystem and positively influencing the immune system.
Biofarma Group to develops and manufactures innovative and effective ready-to-market medical devices, both for third parties and in out-licensing.
Biofarma group deals with the development and production of cosmetic products for third parties promoting environmental sustainability and new beauty concepts.
Biofarma Group develops highly innovative solutions capable of establishing themselves in the market as leading products, accompanied by clinical studies attesting to their effectiveness.
Biofarma Group presents its Sustainability Report 2022 in which it sets out its strategic vision based on 5 pillars: Energy & Emissions Management, Waste Management, Recyclability & Reduction, Corporate Governance & Compliance, Stakeholder Engagement, Economic Performance.
Discover more
From Biofarma Group's R&D laboratories, two innovative nutraceutical products to combat the symptoms of dyspepsia.
Discover more
In silico trials: the latest frontier of scientific research to validate a product against NAFLD
Discover more
Respect and Trust,
Responsability,
Partnership,
Innovation,
Courage.
Wellness
must be spread
and shared
